The Centers for Disease Control and Prevention’s vaccine advisory panel on Friday voted to not recommend the hepatitis B vaccine for everyone at birth, alarming many in the medical community. CBS News medical contributor Dr. Celine Gounder explains what to know about the decision and its potential impact.
Medline debuts on Nasdaq after biggest IPO of 2025
Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the…
